Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Health Rounds: Fewer post-surgery complications found in diabetes patients taking GLP-1 drugs
Hello, Health Rounds Readers! Today we feature a study that found yet another potential health benefit of GLP-1 drugs, this time following surgery in patients with diabetes. We also report on the best way to treat diabetes in pregnancy,
GLP-1s cut surgery complication risk in some patients: Study
Glucagon-like peptide-1 receptor agonist drugs may reduce the risk of surgical complications in diabetic patients, according to a large new study. The study showed diabetic patients taking GLP-1 drugs,
Health Matters: GLP-1 drugs work for weight loss, study finds
McGill University researchers say their study has found GLP-1 drugs are safe and effective for treating obesity and overweight adults without diabetes. The authors say the findings support using the medication to treat those who are overweight and obese among otherwise healthy patients.
21m
GLP-1 Medications Fuel Growth in Medical Aesthetics, with Weight Loss Accounting for 11% of Non-Surgical Spending in 2024
Medspas are leading the charge in offering GLP-1 treatments, with 60% of medspas in the U.S. now providing these services, compared to 35% of aesthetic physician offices. Average spend per patient ...
FoodNavigator
38m
GLP-1 – diet food killer or new opportunity?
Diet food brands have been hit in recent years, but now GLP-1 drugs like Ozempic are hitting the market, will this spell the ...
Fierce Healthcare
1d
Found introducing oral dissolvable GLP-1 tablet at reduced price
Weight management platform Found is today launching oral semaglutide dissolvable tablets for individuals looking for ...
2h
LifeVantage: Bold Move Into The GLP-1 Weight Loss Market Turns Out To Be A Major Winner - Buy
Financial writer recommends buying LifeVantage stock after exceeding Q2/FY2025 expectations with new MindBody GLP-1 System launch.
Convenience Store News
17h
Circana Talks ‘Profound Impact’ GLP-1 Drugs Have on Spending for Food, Beverages, More
This is the beginning of a revolution, and how you engage and how you attack it is going to really set the stage for your ...
FierceBiotech
2d
Metsera links GLP-1 drug to 11% weight loss after 12 weeks, teeing up trial of monthly dosing
Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...
Medscape
2d
Early Intervention Central to Treating Muscle Mass Loss in Patients Losing Weight With GLP-1 Meds
Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...
1d
Gala GLP1: The App Revolutionizing GLP-1 Treatment Management
With its innovative features and the upcoming launch of a direct medication purchasing service, Gala is set to become the ...
FoodNavigator
1d
Which GLP-1 drugs are on the market?
A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?
WGBH
1d
How do GLP-1 drugs work for weight loss?
Dr. Mehmet Furkan Burak said people who have lost weight and then gained it again can feel guilt or shame and blame ...
News Medical on MSN
3d
Do GLP-1 receptor agonists increase the risk of suicide in patients?
A nationwide study confirms GLP-1 RAs pose no short-term psychiatric risk, showing a negative association with suicidal ...
2d
on MSN
GLP-1 makers could be under pressure in 2025
Atlanta Falcons wide receiver Drake London catches a 20-yard touchdown pass from quarterback Michael Penix Jr. "Hey, I’m ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Weight loss
Novo Nordisk
Glucagon-like peptide-1
Ozempic
Circana
Feedback